• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测接受手术切除的肝细胞癌患者无病生存的模型。

Models to predict disease-free survival for hepatocellular carcinoma patients with surgical resections.

机构信息

Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan.

Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

J Surg Oncol. 2020 Dec;122(7):1444-1452. doi: 10.1002/jso.26169. Epub 2020 Sep 1.

DOI:10.1002/jso.26169
PMID:32875573
Abstract

BACKGROUND AND OBJECTIVES

Precise prognostic prediction for an individual hepatocellular carcinoma (HCC) patient before and after liver resection is important. We aimed to establish simple prognostic models to predict disease-free survival (DFS) for these patients.

METHODS

Six hundred and ninety-eight HCC patients with liver resections were reviewed. Preoperative (model 1) and postoperative (model 2) nomogram-based scoring systems were constructed by multivariate analyses, and DFS was estimated.

RESULTS

Among 698 patients, 490 (70.2%) patients had tumor recurrence at a median follow-up of 84.4 months. Risk factors of tumor recurrence in model 1 included viral hepatitis, platelet count, albumin, indocyanine green retention rate, multiplicity of tumor, and radiologic total tumor volume (TTV). Prognostic variables identified in model 2 were viral hepatitis, platelet count, multiplicity of tumor, cirrhosis, microvascular invasion, and pathologic TTV. By nomogram in model 1, the patients were classified into three groups with 5-year DFS of 61.0%, 35.7%, and 21.1%, respectively (P < .0001). In model 2, the patients were divided into five groups with 5-year DFS of 58.0%, 43.7%, 24.0%, 15.4%, and 0.0%, respectively (P < .0001).

CONCLUSION

Based on nomogram models, DFS for the patients who had liver resection for HCC can be predicted before liver resection and re-assessed after liver resection.

摘要

背景与目的

对肝癌(HCC)患者行肝切除术前和术后进行精确的预后预测非常重要。本研究旨在建立简单的预后模型,以预测这些患者的无病生存率(DFS)。

方法

回顾性分析 698 例行肝切除术的 HCC 患者。通过多变量分析建立术前(模型 1)和术后(模型 2)列线图评分系统,并估计 DFS。

结果

在 698 例患者中,490 例(70.2%)患者在中位随访 84.4 个月时发生肿瘤复发。模型 1 中肿瘤复发的危险因素包括病毒性肝炎、血小板计数、白蛋白、吲哚菁绿保留率、肿瘤数量和影像学总肿瘤体积(TTV)。模型 2 中确定的预后变量包括病毒性肝炎、血小板计数、肿瘤数量、肝硬化、微血管侵犯和病理 TTV。通过模型 1 中的列线图,患者被分为三组,5 年 DFS 分别为 61.0%、35.7%和 21.1%(P<0.0001)。在模型 2 中,患者被分为五组,5 年 DFS 分别为 58.0%、43.7%、24.0%、15.4%和 0.0%(P<0.0001)。

结论

基于列线图模型,可在肝切除术前预测 HCC 患者行肝切除术后的 DFS,并在术后重新评估。

相似文献

1
Models to predict disease-free survival for hepatocellular carcinoma patients with surgical resections.用于预测接受手术切除的肝细胞癌患者无病生存的模型。
J Surg Oncol. 2020 Dec;122(7):1444-1452. doi: 10.1002/jso.26169. Epub 2020 Sep 1.
2
A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy.中央型肝细胞癌患者行肝切除术后的长期预后模型预测。
Eur J Surg Oncol. 2018 Oct;44(10):1595-1602. doi: 10.1016/j.ejso.2018.06.009. Epub 2018 Jun 21.
3
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.基于微血管侵犯的新型预后列线图预测肝细胞癌R0切除术后患者的生存结局
J Cancer Res Clin Oncol. 2017 Feb;143(2):293-303. doi: 10.1007/s00432-016-2286-1. Epub 2016 Oct 14.
4
Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.用于术前评估接受根治性切除的巴塞罗那临床肝癌分期A1期以上肝细胞癌患者长期生存情况的列线图。
Oncotarget. 2016 Sep 20;7(38):61378-61389. doi: 10.18632/oncotarget.11358.
5
Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy.肝癌患者手术后极早期预后列线图和结局风险分类。
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):681-689. doi: 10.1016/j.ejso.2020.10.039. Epub 2020 Oct 31.
6
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.建立预测 Child-Pugh B 级肝硬化肝癌患者肝切除术后结局的列线图。
J Hepatol. 2020 Jan;72(1):75-84. doi: 10.1016/j.jhep.2019.08.032. Epub 2019 Sep 6.
7
Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.用于预测米兰标准内肝细胞癌肝切除术后无病生存期的验证列线图:个体化监测策略
Surg Today. 2019 Jun;49(6):521-528. doi: 10.1007/s00595-019-1764-x. Epub 2019 Jan 14.
8
Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.新型微血管侵犯肝细胞癌患者预后列线图:单中心经验。
Gut Liver. 2019 Nov 15;13(6):669-682. doi: 10.5009/gnl18489.
9
Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.基于控制营养状态(CONUT)评分的列线图预测 HBV 相关肝细胞癌患者根治性肝切除术后的总生存。
Clin Transl Oncol. 2020 Mar;22(3):370-380. doi: 10.1007/s12094-019-02137-4. Epub 2019 Jun 14.
10
Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy.列线图预测肝癌术后单发肿瘤患者的个体生存情况。
Gut Liver. 2017 Sep 15;11(5):684-692. doi: 10.5009/gnl16465.

引用本文的文献

1
Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple Tumors Based on Total Tumor Volume.基于肿瘤总体积的肝癌多结节患者肝切除术标准。
Dig Dis Sci. 2024 Aug;69(8):3069-3078. doi: 10.1007/s10620-024-08500-y. Epub 2024 Jun 1.
2
Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection.原发性肝癌切除术后基于生物标志物和影像学指标的生存率曲线模型的建立与应用。
Cancer Med. 2023 Jun;12(12):13329-13341. doi: 10.1002/cam4.6031. Epub 2023 May 11.
3
Comparison of quantitative volumetric analysis and linear measurement for predicting the survival of Barcelona Clinic Liver Cancer 0- and A stage hepatocellular carcinoma after radiofrequency ablation.
定量容积分析与线性测量在预测巴塞罗那临床肝癌 0 期和 A 期肝癌经射频消融治疗后生存的比较。
Diagn Interv Radiol. 2023 May 31;29(3):450-459. doi: 10.4274/dir.2023.222055. Epub 2023 May 8.
4
Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting Antivirals.直接抗病毒药物时代病毒性肝炎状态与肝切除术后结局的关联
Ann Surg Oncol. 2023 May;30(5):2793-2802. doi: 10.1245/s10434-022-12937-8. Epub 2022 Dec 14.
5
Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections.用于预测接受手术切除的肝细胞癌患者无病生存期的改良术前评分。
World J Hepatol. 2022 Sep 27;14(9):1778-1789. doi: 10.4254/wjh.v14.i9.1778.